Condition: Acute Kidney Injury Requiring Continuous Renal Replacement Therapy · Sponsor: Jikei University School of Medicine
This clinical trial aims to investigate whether the low treatment intensity (12 mL/kg/hr, low-dose hemodialysis/filtration) or the medium treatment intensity (25 mL/kg/hr, standard-dose hemodialysis/filtration) is more effective and safer for continuous renal replacement therapy in critically ill patients.
This description comes directly from the study's public registry record.
Tomoko Fujii, MD,PhD · +81 3 3433 1111 · tofujii-tky@umin.net
Always discuss trial participation with your own doctor first.
| Sendai Medical Center | Sendai, Miyagi, Japan | Not Yet Recruiting |
| Osaka Medical and Pharmaceutical University Hospital | Takatsuki, Osaka, Japan | Not Yet Recruiting |
| University of Fukui Hospital | Fukui, Japan | Not Yet Recruiting |
| Tsuchiura Kyodo General Hospital | Ibaraki, Japan | Recruiting |
| Osaka University Hospital | Osaka, Japan | Not Yet Recruiting |
| Jichi Medical University Hospital | Tochigi, Japan | Not Yet Recruiting |
| Jikei University Hospital | Tokyo, Japan | Recruiting |
| Keio University Hospital | Tokyo, Japan | Recruiting |
| Wakayama Medical University Hospital | Wakayama, Japan | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06014801